Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997???2006, British Journal of Cancer, vol.44, issue.7, pp.947-953, 1997. ,
DOI : 10.1158/1078-0432.CCR-09-0371
Incidence of venous thromboembolism in patients with cancer ??? A cohort study using linked United Kingdom databases, European Journal of Cancer, vol.49, issue.6, pp.1404-1413, 2013. ,
DOI : 10.1016/j.ejca.2012.10.021
Epidemiology of cancer-associated venous thrombosis, Blood, vol.122, issue.10, pp.1712-1723, 2013. ,
DOI : 10.1182/blood-2013-04-460121
Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study, Cancer, vol.342, issue.3, pp.468-475, 2016. ,
DOI : 10.1056/NEJM200006293422604
When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data, Blood, vol.127, issue.7, pp.849-857, 2016. ,
DOI : 10.1182/blood-2015-01-625582
Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis, JNCI: Journal of the National Cancer Institute, vol.103, issue.17, pp.1299-1309, 2011. ,
DOI : 10.1093/jnci/djr242
Breast cancer and thrombosis: timing matters, Blood, vol.127, issue.7, pp.793-794, 2016. ,
DOI : 10.1182/blood-2015-12-683482
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients, Journal of Clinical Oncology, vol.21, issue.19, pp.3665-3675, 2003. ,
DOI : 10.1200/JCO.2003.08.008
Epidemiology and prevention of catheter-related thrombosis in patients with cancer, Journal of Thrombosis and Haemostasis, vol.4, issue.Suppl. 6, pp.1491-1499, 2012. ,
DOI : 10.1002/jhm.442
Preventing Complications of Central Venous Catheterization, New England Journal of Medicine, vol.348, issue.12, pp.1123-1133, 2003. ,
DOI : 10.1056/NEJMra011883
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer, The Lancet Oncology, vol.17, issue.10, pp.452-466, 2016. ,
DOI : 10.1016/S1470-2045(16)30369-2
Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline, Journal of Clinical Oncology, vol.31, issue.10, pp.1357-1370, 2013. ,
DOI : 10.1200/JCO.2012.45.5733
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, Journal of Thrombosis and Haemostasis, vol.9, issue.Suppl 6, pp.71-80, 2013. ,
DOI : 10.1111/j.1538-7836.2010.04126.x
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group, Annals of Oncology, vol.20, issue.9, pp.1459-1471, 2008. ,
DOI : 10.1093/annonc/mdp052
URL : https://hal.archives-ouvertes.fr/ujm-00439715
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies, Journal of Thrombosis and Haemostasis, vol.15, issue.2, pp.312-319, 2011. ,
DOI : 10.1093/annonc/mdh146
Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound, British Journal of Haematology, vol.114, issue.3, pp.507-512, 2003. ,
DOI : 10.1001/archsurg.1972.04180020014004
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?, Journal of Thrombosis and Haemostasis, vol.16, issue.1, pp.190-197, 2009. ,
DOI : 10.1002/cyto.a.20354
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men, New England Journal of Medicine, vol.332, issue.14, 1995. ,
DOI : 10.1056/NEJM199504063321403
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, pp.3698-3703, 1996. ,
Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study, Journal of Clinical Oncology, vol.29, issue.15, pp.2099-2103, 2011. ,
DOI : 10.1200/JCO.2010.32.8294
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis, PLoS Medicine, vol.9, issue.7, p.1001275, 2012. ,
DOI : 10.1371/journal.pmed.1001275.s014
Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients, Circulation, vol.110, issue.12, pp.1605-1611, 2004. ,
DOI : 10.1161/01.CIR.0000142289.94369.D7
Thrombotic Complications of Central Venous Catheters in Cancer Patients, The Oncologist, vol.9, issue.2, pp.207-216, 2004. ,
DOI : 10.1634/theoncologist.9-2-207
Thrombose symptomatique sur cath??ter veineux central de longue dur??e en oncologie??: un score de risque pr??dictif?, La Revue de M??decine Interne, vol.26, issue.4, pp.273-279, 2005. ,
DOI : 10.1016/j.revmed.2004.11.017
Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer, Journal of Clinical Oncology, vol.24, issue.9, pp.1404-1408, 2006. ,
DOI : 10.1200/JCO.2005.03.5600
Pulmonary embolism in patients with upper extremity DVT associated to venous central lines?a prospective study, Thromb. Haemost, vol.72, pp.548-550, 1994. ,
Central venous access sites for the prevention of venous thrombosis, stenosis and infection, Cochrane Database Syst. Rev, vol.24, issue.3, p.4084, 2012. ,
DOI : 10.1002/14651858.CD004084.pub2
Development and validation of a predictive model for chemotherapy-associated thrombosis, Blood, vol.111, issue.10, pp.4902-4907, 2008. ,
DOI : 10.1182/blood-2007-10-116327
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer, Breast Cancer Research and Treatment, vol.25, issue.28, pp.35-43, 2012. ,
DOI : 10.1200/JCO.2007.10.6823
Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-741, 2002. ,
DOI : 10.1001/jama.287.6.734
Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer, Breast Cancer, vol.121, issue.5, pp.667-672, 2017. ,
DOI : 10.1053/gast.2001.29611
Female Hormones and Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.2, pp.201-210, 2002. ,
DOI : 10.1161/hq0202.102318
Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis, Haematologica, vol.90, pp.499-504, 2005. ,
Elevation of plasma D-dimer is closely associated with venous thrombosis produced by double-lumen catheter in pre-dialysis patients, Nephrology Dialysis Transplantation, vol.22, issue.4, pp.1224-1227, 2007. ,
DOI : 10.1093/ndt/gfl845
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, Blood, vol.122, issue.11, pp.1873-1880, 2013. ,
DOI : 10.1182/blood-2013-04-460139
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters, European Journal of Pediatrics, vol.158, issue.S3, pp.158-143, 1999. ,
DOI : 10.1007/PL00014341
Factor V Leiden in central venous catheter-associated thrombosis, British Journal of Haematology, vol.6, issue.1, pp.267-270, 2002. ,
DOI : 10.1016/S0140-6736(94)92939-4
The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis, Haematologica, vol.89, pp.201-206, 2004. ,
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter, Annals of Oncology, vol.15, issue.4, pp.590-593, 2004. ,
DOI : 10.1093/annonc/mdh146
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014, Journal of Clinical Oncology, vol.33, issue.6, pp.654-656, 2015. ,
DOI : 10.1200/JCO.2014.59.7351
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial, The Lancet, vol.373, issue.9663, pp.567-574, 2009. ,
DOI : 10.1016/S0140-6736(09)60205-1
Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies, Annals of Oncology, vol.20, issue.12, pp.1936-1942, 2009. ,
DOI : 10.1093/annonc/mdp235
Anticoagulation for Central Venous Catheters in Patients with Cancer, New England Journal of Medicine, vol.371, issue.14, pp.1362-1363, 2014. ,
DOI : 10.1056/NEJMc1408861